Kawabata H, Ono Y, Tamamura N, Oyama K, et al. Mutant GNAS limits tumor aggressiveness in established pancreatic cancer via antagonizing the KRAS-pathway. J Gastroenterol 2022 Jan 11. pii: 10.1007/s00535-021-01846.
PMID: 35018527